Illumina, Myriad Genetics expand partnership to broaden access to HRD testing in U.S.
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
13,295$
0,38%
Echtzeit-Aktienkurs Myriad Genetics Inc.
Bid:
Ask:
Nachrichten zur Myriad Genetics Inc. Aktie
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry Strategic partnership offers a…
Myriad Genetics surges 15% amid strong 2023 guidance, quarterly top and bottom line beats
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics (MYGN) Q4 Earnings Top, Gross Margin Falls
Myriad Genetics (MYGN) hereditary cancer testing volume registered strong growth in the fourth quarter. GeneSight comes up with yet another…
Form 10-K MYRIAD GENETICS INC For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics (MYGN) Reports Q4 Loss, Tops Revenue Estimates
Myriad (MYGN) delivered earnings and revenue surprises of 25% and 5.11%, respectively, for the quarter ended December 2022. Do the…
Myriad Genetics Inc. Q4 Loss Increases, but beats estimates
WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released Loss for its fourth quarter that increased from last year and missed…
Myriad Genetics Non-GAAP EPS of -$0.12 beats by $0.05, revenue of $177.8M beats by $8.38M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Preview For Myriad Genetics
read more...…
Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023
SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
United States Women Health Laboratory Testing Markets Report 2022-2030 Featuring Ascension, EKF, Gateway Genomics, Laboratory Corp of America, Myriad Genetics, Natera, Ovia Health, Roche, & Yourgene
DUBLIN, Feb. 20, 2023 /PRNewswire/ -- The "U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S.…
Myriad Genetics to Participate in Upcoming Healthcare Conferences
SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing
SALT LAKE CITY, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Insiderhandel: Chief Financial Officer verkauft Aktien von Myriad Genetics im Wert von 188.386$
Riggsbee, Richard Bryan - Vorstand - Tag der Transaktion: 2023-01-20...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Myriad Genetics im Wert von 12.006$
Riggsbee, Richard Bryan - Vorstand - Tag der Transaktion: 2023-01-18...…
Myriad Genetics upgraded to outperform from market perform at Raymond James
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics (MYGN) Ailed by Mounting Costs, FX Headwind
Myriad Genetics (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning....…
Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities
SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…